| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cytochrome P450 3A5 |
|---|
| Ligand | BDBM50113979 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_1511049 (CHEMBL3607269) |
|---|
| IC50 | >20000±n/a nM |
|---|
| Citation |  Hennessy, EJ; Oza, V; Adam, A; Byth, K; Castriotta, L; Grewal, G; Hamilton, GA; Kamhi, VM; Lewis, P; Li, D; Lyne, P; ึster, L; Rooney, MT; Saeh, JC; Sha, L; Su, Q; Wen, S; Xue, Y; Yang, B Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity. J Med Chem58:7057-75 (2015) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Cytochrome P450 3A5 |
|---|
| Name: | Cytochrome P450 3A5 |
|---|
| Synonyms: | CP3A5_HUMAN | CYP3A5 | Cytochrome P450 3A5 | Cytochrome P450 3A5 (CYP3A5) |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 57118.00 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P20815 |
|---|
| Residue: | 502 |
|---|
| Sequence: | MDLIPNLAVETWLLLAVSLVLLYLYGTRTHGLFKRLGIPGPTPLPLLGNVLSYRQGLWKF
DTECYKKYGKMWGTYEGQLPVLAITDPDVIRTVLVKECYSVFTNRRSLGPVGFMKSAISL
AEDEEWKRIRSLLSPTFTSGKLKEMFPIIAQYGDVLVRNLRREAEKGKPVTLKDIFGAYS
MDVITGTSFGVNIDSLNNPQDPFVESTKKFLKFGFLDPLFLSIILFPFLTPVFEALNVSL
FPKDTINFLSKSVNRMKKSRLNDKQKHRLDFLQLMIDSQNSKETESHKALSDLELAAQSI
IFIFAGYETTSSVLSFTLYELATHPDVQQKLQKEIDAVLPNKAPPTYDAVVQMEYLDMVV
NETLRLFPVAIRLERTCKKDVEINGVFIPKGSMVVIPTYALHHDPKYWTEPEEFRPERFS
KKKDSIDPYIYTPFGTGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLDTQG
LLQPEKPIVLKVDSRDGTLSGE
|
|
|
|---|
| BDBM50113979 |
|---|
| n/a |
|---|
| Name | BDBM50113979 |
|---|
| Synonyms: | CHEMBL3605558 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C19H20N6O2S |
|---|
| Mol. Mass. | 396.466 |
|---|
| SMILES | CCn1c(nc2cnc(cc12)C1CC1)[C@@H](C)NS(=O)(=O)c1ccc(nc1)C#N |r| |
|---|
| Structure | 
|
|---|
Search and Browse
